These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31712584)

  • 21. Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism.
    Chantiluke K; Barrett N; Giampietro V; Brammer M; Simmons A; Murphy DG; Rubia K
    Cereb Cortex; 2015 Jul; 25(7):1757-70. PubMed ID: 24451919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
    BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Language comprehension and brain function in individuals with an optimal outcome from autism.
    Eigsti IM; Stevens MC; Schultz RT; Barton M; Kelley E; Naigles L; Orinstein A; Troyb E; Fein DA
    Neuroimage Clin; 2016; 10():182-91. PubMed ID: 26862477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical and subcortical alterations associated with precision visuomotor behavior in individuals with autism spectrum disorder.
    Unruh KE; Martin LE; Magnon G; Vaillancourt DE; Sweeney JA; Mosconi MW
    J Neurophysiol; 2019 Oct; 122(4):1330-1341. PubMed ID: 31314644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse fluoxetine effects on inhibitory brain activation in non-comorbid boys with ADHD and with ASD.
    Chantiluke K; Barrett N; Giampietro V; Santosh P; Brammer M; Simmons A; Murphy DG; Rubia K
    Psychopharmacology (Berl); 2015 Jun; 232(12):2071-82. PubMed ID: 25533997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder.
    Ajram LA; Horder J; Mendez MA; Galanopoulos A; Brennan LP; Wichers RH; Robertson DM; Murphy CM; Zinkstok J; Ivin G; Heasman M; Meek D; Tricklebank MD; Barker GJ; Lythgoe DJ; Edden RAE; Williams SC; Murphy DGM; McAlonan GM
    Transl Psychiatry; 2017 May; 7(5):e1137. PubMed ID: 28534874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.
    Schrantee A; Lucassen PJ; Booij J; Reneman L
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1173-1179. PubMed ID: 30082141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval.
    Reed MB; Vanicek T; Seiger R; Klöbl M; Spurny B; Handschuh P; Ritter V; Unterholzner J; Godbersen GM; Gryglewski G; Kraus C; Winkler D; Hahn A; Lanzenberger R
    Neuroimage; 2021 Aug; 236():118039. PubMed ID: 33852940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin transporter polymorphism alters citalopram effects on human pain responses to physical pain.
    Ma Y; Wang C; Luo S; Li B; Wager TD; Zhang W; Rao Y; Han S
    Neuroimage; 2016 Jul; 135():186-96. PubMed ID: 27132044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
    Ye Z; Rae CL; Nombela C; Ham T; Rittman T; Jones PS; Rodríguez PV; Coyle-Gilchrist I; Regenthal R; Altena E; Housden CR; Maxwell H; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
    Hum Brain Mapp; 2016 Mar; 37(3):1026-37. PubMed ID: 26757216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
    Kolevzon A; Mathewson KA; Hollander E
    J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Executive function and functional and structural brain differences in middle-age adults with autism spectrum disorder.
    Braden BB; Smith CJ; Thompson A; Glaspy TK; Wood E; Vatsa D; Abbott AE; McGee SC; Baxter LC
    Autism Res; 2017 Dec; 10(12):1945-1959. PubMed ID: 28940848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Intravenous Citalopram on the Neural Substrates of Obsessive-Compulsive Disorder.
    Bhikram TP; Farb NA; Ravindran LN; Papadopoulos YG; Conn DK; Pollock BG; Ravindran AV
    J Neuropsychiatry Clin Neurosci; 2016; 28(3):243-7. PubMed ID: 27019066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopram.
    Arnone D; Wise T; Walker C; Cowen PJ; Howes O; Selvaraj S
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):152-159. PubMed ID: 29409920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor.
    Bhagwagar Z; Wylezinska M; Taylor M; Jezzard P; Matthews PM; Cowen PJ
    Am J Psychiatry; 2004 Feb; 161(2):368-70. PubMed ID: 14754790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin.
    Pretzsch CM; Floris DL; Voinescu B; Elsahib M; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Pretzsch E; Williams S; Murphy DGM; Daly E; McAlonan GM
    Mol Autism; 2021 Jul; 12(1):49. PubMed ID: 34210360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study.
    Solleveld MM; Schrantee A; Homberg JR; Lucassen PJ; Reneman L
    Psychiatry Res Neuroimaging; 2020 Sep; 303():111126. PubMed ID: 32592855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant functional connectivity of inhibitory control networks in children with autism spectrum disorder.
    Voorhies W; Dajani DR; Vij SG; Shankar S; Turan TO; Uddin LQ
    Autism Res; 2018 Nov; 11(11):1468-1478. PubMed ID: 30270514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.